AEGERION PHARMACEUTICALS INC's ticker is AEGR and the CUSIP is 00767E102.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $1,782,000 | +95.8% | 600,132 | -1.7% | 0.00% | – |
| Q2 2016 | $910,000 | -67.8% | 610,671 | -20.1% | 0.00% | – |
| Q1 2016 | $2,827,000 | -63.4% | 764,166 | -0.2% | 0.00% | -100.0% |
| Q4 2015 | $7,732,000 | -24.5% | 765,527 | +1.6% | 0.00% | -50.0% |
| Q3 2015 | $10,244,000 | -27.1% | 753,227 | +1.7% | 0.00% | 0.0% |
| Q2 2015 | $14,048,000 | -33.6% | 740,541 | -8.3% | 0.00% | -33.3% |
| Q1 2015 | $21,144,000 | +25.0% | 807,965 | -0.0% | 0.00% | 0.0% |
| Q4 2014 | $16,919,000 | -40.8% | 807,995 | -5.6% | 0.00% | -40.0% |
| Q3 2014 | $28,568,000 | +11.0% | 855,830 | +6.7% | 0.01% | +25.0% |
| Q2 2014 | $25,739,000 | -26.8% | 802,078 | +5.4% | 0.00% | -33.3% |
| Q1 2014 | $35,153,000 | -32.2% | 761,212 | +4.2% | 0.01% | -33.3% |
| Q4 2013 | $51,826,000 | -8.2% | 730,360 | +11.0% | 0.01% | -18.2% |
| Q3 2013 | $56,445,000 | +50.6% | 658,246 | +11.2% | 0.01% | +37.5% |
| Q2 2013 | $37,483,000 | – | 591,778 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 4,656,682 | $399,310,000 | 16.44% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,300,000 | $111,475,000 | 5.48% |
| ADVENT INTERNATIONAL, L.P. | 705,300 | $60,479,000 | 5.01% |
| Antipodean Advisors LLC | 266,400 | $22,844,000 | 2.38% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 489,181 | $41,928,000 | 2.06% |
| HealthCor Management, L.P. | 425,000 | $36,444,000 | 1.95% |
| Cupps Capital Management, LLC | 290,489 | $24,909,000 | 1.62% |
| Zweig-DiMenna Associates LLC | 421,400 | $36,135,000 | 1.46% |
| SABBY MANAGEMENT, LLC | 259,119 | $22,209,000 | 1.44% |
| Independence Capital Asset Partners, LLC | 98,070 | $8,410,000 | 1.43% |